Long-Term Results of Aortic Root Surgery in Marfan Syndrome Patients: A Single-Center Experience.

Q3 Medicine Journal of Heart Valve Disease Pub Date : 2017-07-01
Francesco Nicolo, Francesco Romeo, Antonio Lio, Emanuele Bovio, Antonio Scafuri, Carlo Bassano, Patrizio Polisca, Antonio Pellegrino, Paolo Nardi, Luigi Chiariello, Giovanni Ruvolo
{"title":"Long-Term Results of Aortic Root Surgery in Marfan Syndrome Patients: A Single-Center Experience.","authors":"Francesco Nicolo,&nbsp;Francesco Romeo,&nbsp;Antonio Lio,&nbsp;Emanuele Bovio,&nbsp;Antonio Scafuri,&nbsp;Carlo Bassano,&nbsp;Patrizio Polisca,&nbsp;Antonio Pellegrino,&nbsp;Paolo Nardi,&nbsp;Luigi Chiariello,&nbsp;Giovanni Ruvolo","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aim of the study: </strong>The study aim was to compare long-term results of Marfan syndrome (MFS) patients affected by aortic root disease undergoing aortic root replacement with the Bentall or David operation.</p><p><strong>Methods: </strong>Since 1994, a total of 59 patients has been followed at the authors' Marfan Center, having undergone either a Bentall operation (Bentall group, n = 30) or a David operation (David group, n = 29).</p><p><strong>Results: </strong>No operative mortality was recorded. After 20 years (mean follow up 97 ± 82 months; range 1 to 369 months) no prosthesis-related major bleeding or thromboembolic events had been observed; the 20-year survival was 94 ± 6% in the Bentall group, and 100% in the David group (p = 0.32). Freedom from reintervention for aortic valve dysfunction was 100% in the Bentall group, and 75 ± 13% in the David group (p = 0.04). This inter-group difference became relevant after the first eight-year period of follow-up, and was mainly associated with a particular familiar genetic phenotype involving three out of four reoperated patients. Freedom from all-cause death, myocardial infarction, stroke, prosthetic valve-related complications, and reintervention on any aortic segment was 69 ± 12% in the Bentall group, and 67 ± 14% in the David group (p = 0.33).</p><p><strong>Conclusions: </strong>The Bentall and David operations are both associated with satisfactory long-term results in MFS patients. The low rate of valve prosthesis-related complications suggested that the Bentall operation would continue to be a standard surgical treatment. The reimplantation technique, adopted for less-dilated aortas, provides satisfactory freedom from reoperation. Careful attention should be paid to the reimplantation technique in patients affected by a serious familiar genetic phenotype.</p>","PeriodicalId":50184,"journal":{"name":"Journal of Heart Valve Disease","volume":"26 4","pages":"397-404"},"PeriodicalIF":0.0000,"publicationDate":"2017-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Heart Valve Disease","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background and aim of the study: The study aim was to compare long-term results of Marfan syndrome (MFS) patients affected by aortic root disease undergoing aortic root replacement with the Bentall or David operation.

Methods: Since 1994, a total of 59 patients has been followed at the authors' Marfan Center, having undergone either a Bentall operation (Bentall group, n = 30) or a David operation (David group, n = 29).

Results: No operative mortality was recorded. After 20 years (mean follow up 97 ± 82 months; range 1 to 369 months) no prosthesis-related major bleeding or thromboembolic events had been observed; the 20-year survival was 94 ± 6% in the Bentall group, and 100% in the David group (p = 0.32). Freedom from reintervention for aortic valve dysfunction was 100% in the Bentall group, and 75 ± 13% in the David group (p = 0.04). This inter-group difference became relevant after the first eight-year period of follow-up, and was mainly associated with a particular familiar genetic phenotype involving three out of four reoperated patients. Freedom from all-cause death, myocardial infarction, stroke, prosthetic valve-related complications, and reintervention on any aortic segment was 69 ± 12% in the Bentall group, and 67 ± 14% in the David group (p = 0.33).

Conclusions: The Bentall and David operations are both associated with satisfactory long-term results in MFS patients. The low rate of valve prosthesis-related complications suggested that the Bentall operation would continue to be a standard surgical treatment. The reimplantation technique, adopted for less-dilated aortas, provides satisfactory freedom from reoperation. Careful attention should be paid to the reimplantation technique in patients affected by a serious familiar genetic phenotype.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
马凡氏综合征患者主动脉根部手术的长期结果:单中心经验。
研究背景和目的:研究目的是比较经主动脉根疾病影响的马凡综合征(MFS)患者行主动脉根置换术与Bentall或David手术的长期疗效。方法:自1994年以来,作者Marfan中心共随访59例患者,分别行Bentall手术(Bentall组,n = 30)和David手术(David组,n = 29)。结果:无手术死亡记录。20年后(平均随访97±82个月);范围1 ~ 369个月)未观察到与假体相关的大出血或血栓栓塞事件;Bentall组20年生存率为94±6%,David组20年生存率为100% (p = 0.32)。本特尔组因主动脉瓣功能障碍再干预率为100%,戴维组为75±13% (p = 0.04)。在第一个8年的随访期后,这种组间差异变得相关,并且主要与涉及四分之三的再手术患者的特定熟悉的遗传表型相关。Bentall组无全因死亡、心肌梗死、卒中、人工瓣膜相关并发症和主动脉段再干预的发生率为69±12%,David组为67±14% (p = 0.33)。结论:本特尔手术和大卫手术对MFS患者均有满意的远期疗效。瓣膜假体相关并发症的低发生率表明本特尔手术将继续作为一种标准的外科治疗方法。主动脉再植技术用于扩张程度较低的主动脉,可提供满意的再手术自由。对于受严重常见遗传表型影响的患者,应注意再植技术。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Heart Valve Disease
Journal of Heart Valve Disease 医学-心血管系统
CiteScore
1.00
自引率
0.00%
发文量
0
审稿时长
4-8 weeks
期刊介绍: The Journal of Heart Valve Disease (ISSN 0966-8519) is the official journal of The Society for Heart Valve Disease. It is indexed/abstracted by Index Medicus, Medline, Medlar, PubMed, Science Citation Index, Scisearch, Research Alert, Biomedical Products, Current Contents/Clinical Medicine. It is issued bi-monthly in one indexed volume by ICR Publishers Ltd., Crispin House, 12A South Approach, Moor Park, Northwood HA6 2ET, United Kingdom. This paper meets the requirements of ANSI standard Z39.48-1992 (Permanence of Paper).
期刊最新文献
ABO Blood Group: A Risk Factor for a Cardiovascular Disease in Adults in Morocco Anti-Hypertensive Medication in Geriatric Population with HFpEF Comparison of Clinical Characteristics and Outcomes in Patients with STEMI in Croatia and Kosovo Radiofrequency Ablation of Ventricular Arrhythmias on Bioprosthetic Valve, a Never Found Case Before An Interesting Case of Heart Failure in a Patient with Bicuspid Aortic Valve - Unveiling the Diagnosis of Amyloidosis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1